Four-year paracorporeal left ventricular assist device (LVAD) support for heart failure after Rastelli operation.

Abstract

It is well known that heart failure can occur after a conventional Rastelli operation (using an anatomical right ventricle as a systemic ventricle) in patients with congenitally corrected transposition of the great arteries (CCTGA). At present, heart transplantation (HTx) is the only definitive therapy known to save such patients. The left ventricular assist device (LVAD) has been employed for patients presenting with acute deterioration of chronic heart failure as a bridge to transplantation when early HTx is not feasible. LVAD implantation in postoperative cases and/or in patients with dextrocardia is often difficult because of the complex anatomy. We report the case of a 26-year-old male patient with CCTGA who presented with heart failure after a conventional Rastelli operation and in whom paracorporeal LVAD implantation was undertaken for the management of right (systemic) ventricular failure. The patient recovered from the heart failure and remained on the HTx list for approximately 4 years with LVAD support.

• Authors: Takafumi Inoue, Takashi Nishimura, Arata Murakami, Osamu Kinoshita, Shunei Kyo, Minoru Ono
• Journal: Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs (J Artif Organs) Vol. 16 Issue 4 Pg. 501-3 (Dec 2013) ISSN: 1619-0904 [Electronic] Japan
• PMID: 23832714 (Publication Type: Case Reports, Journal Article)

Topics

• Adult
• Congenitally Corrected Transposition of the Great Arteries
• Heart Failure (therapy)
• Heart Valve Prosthesis
• Heart Valve Prosthesis Implantation
• Heart-Assist Devices
• Humans
• Male
• Postoperative Complications (therapy)
• Transposition of Great Vessels (surgery)
• Tricuspid Valve
• Tricuspid Valve Insufficiency (surgery)